Cetuximab (PBS) is a human IgG1 monoclonal antibody that can inhibit EGFR. The SPR method measured the Kd value of Cetuximab for EGFR to be 0.201 nM, Cetuximab has a highly effective anti-tumor effect[1].
Molecular Weight:
(145.54 kDa)
Purity:
99.33
Target:
EGFR,Radionuclide-Drug Conjugates (RDCs)
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
